Procaps Group, S.A. (PROC): Price and Financial Metrics


Procaps Group, S.A. (PROC): $6.61

0.01 (+0.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PROC Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for PROC is -45.44 -- better than just 0.44% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -20 for PROCAPS GROUP SA; that's greater than it is for just 1.22% of US stocks.
  • As for revenue growth, note that PROC's revenue has grown -18.75% over the past 12 months; that beats the revenue growth of merely 9.01% of US companies in our set.
  • Stocks that are quantitatively similar to PROC, based on their financial statements, market capitalization, and price volatility, are JILL, STCN, MKTW, HHS, and CYH.
  • Visit PROC's SEC page to see the company's official filings. To visit the company's web site, go to uac-ii.

PROC Valuation Summary

  • PROC's price/sales ratio is 1.8; this is 5.26% lower than that of the median Healthcare stock.
  • PROC's price/sales ratio has moved NA NA over the prior 37 months.

Below are key valuation metrics over time for PROC.

Stock Date P/S P/B P/E EV/EBIT
PROC 2022-11-01 1.8 -27.3 -10.6 -193.1
PROC 2022-10-31 1.9 -29.0 -11.3 -202.9
PROC 2022-10-28 1.8 -26.8 -10.4 -190.8
PROC 2022-10-27 1.8 -27.2 -10.6 -192.7
PROC 2022-10-26 1.8 -27.5 -10.7 -194.2
PROC 2022-10-25 1.8 -26.4 -10.3 -188.4

PROC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PROC has a Quality Grade of C, ranking ahead of 50.56% of graded US stocks.
  • PROC's asset turnover comes in at 1.638 -- ranking 7th of 680 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows PROC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 1.638 0.577 0.193
2020-09-30 0.000 NA 0.002

PROC Stock Price Chart Interactive Chart >

Price chart for PROC

PROC Price/Volume Stats

Current price $6.61 52-week high $10.49
Prev. close $6.60 52-week low $5.86
Day low $6.60 Volume 2,800
Day high $6.70 Avg. volume 25,921
50-day MA $6.93 Dividend yield N/A
200-day MA $8.05 Market Cap 745.74M

Procaps Group, S.A. (PROC) Company Bio


Procaps Group, S.A. develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and clinical solutions. It operates in 13 countries in Latin America. The company was founded in 1977 and is based in Luxembourg City, Luxembourg


PROC Latest News Stream


Event/Time News Detail
Loading, please wait...

PROC Latest Social Stream


Loading social stream, please wait...

View Full PROC Social Stream

Latest PROC News From Around the Web

Below are the latest news stories about PROCAPS GROUP SA that investors may wish to consider to help them evaluate PROC as an investment opportunity.

Procaps Group Reports Third Quarter and Nine Months 2022 Results

Constant currency Net Revenues Increased by 15% year-over-year in the 9M22 and by 11% in the 3Q22, signaling a strong demand across our businessesMIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its financial results for the three months ended September 30, 2022 (“3Q22”) and the nine months ended September 30, 2022 (“9M22”). “Demand remains robu

Yahoo | November 14, 2022

Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022

MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it expects to report its results for the third quarter ended September 30, 2022, after the market closes on Monday, November 14, 2022. The Company expects to host a conference call and webcast at 04 p.m. Eastern time, on November 16, 2022.To access the call, please use the following information: Date:We

Yahoo | November 8, 2022

Procaps Announces ESG Commitments and Initiatives with Inaugural Report

MIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the completion of its inaugural 2021 ESG Annual Report, a comprehensive overview of environmental, social and governance metrics and corresponding strategies and initiatives for ESG priorities. Procaps commitments and initiatives include advancing a healthy, climate-resilient future, social responsibil

Yahoo | October 11, 2022

Procaps Group to Participate in the BTG Pactual LatAm CEO Conference

MIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced it will participate in the BTG Pactual LatAm CEO Conference being held at the InterContinental NY Barclays Hotel October 11-13, 2022. Procaps Group Chief Executive Officer Rubén Minski, Chief Financial Officer Patricio Vargas, and Investor Relations Director Melissa Angelini will conduct in-person one-

Yahoo | October 5, 2022

Procaps Group Reports Second Quarter and First Half 2022 Results

Net Revenues Increased 14% year-over-year in the Second Quarter, with Adjusted EBITDA Margin of 24%Constant currency Net Revenues Increased by 18% year-over-year in the First Half, signaling a strong demand across our businesses MIAMI and BARRANQUILLA, Colombia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its financial results for the three months ended June 30, 2022 (“2Q22

Yahoo | August 30, 2022

Read More 'PROC' Stories Here

PROC Price Returns

1-mo -2.94%
3-mo -9.45%
6-mo -22.33%
1-year -29.76%
3-year N/A
5-year N/A
YTD -32.21%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7056 seconds.